During bone metastatic progression, osteolytic cancer cells—originating from primary tumors from breast cancer, lung cancer, renal cancer, sarcomas, and multiple myeloma, etc.—stimulate osteoblasts to release RANKL. This evidence concerns the gene TNFSF11 and cancer.